Imagine
evolution-inspired medicine
We develop disease-modifying therapies to offer hope for patients with neuro- and metabolic diseases
Pioneers in the discovery of modifier genes to enable the development of transformative therapeutics
Scenic Biotech is advancing modifier therapy, a radically new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, modifier therapy seeks to rebalance health by acting on another function in the genome that can neutralize the disease impact, leading to a therapeutic effect.
Just as gene mutations can cause disease, we now know they can also protect us from disease. We use our unique platform to identify novel targets that re-balance disease pathways and open them up to alternative approaches for pharmacological intervention.
Modifier genes – a new class of therapeutic drug targets
Scenic Biotech has overcome the technical challenges of reliably finding modifier genes or the “hidden disease protection factors” using Cell-Seq, its unique discovery platform. This has resulted in a rapidly growing pipeline of novel disease therapeutics for neuro- and metabolic diseases, and collaborations with established pharma companies, such as Alnylam, Bristol Myers Squibb and Genentech.
